Biovica Inc is a biotechnology company based in San Diego, CA that specializes in the development and commercialization of innovative biomarker assays for cancer diagnostics. Their flagship product, DiviTum TKa, is a CE-marked and FDA 510(k) cleared biomarker assay that can be used in both prospective clinical trials and retrospective analysis of banked patient samples. With a team of medical experts, Biovica offers consultation services for clinical trial set-up, data analysis, and interpretation, providing valuable insights for patient selection and treatment response.
With a focus on precision medicine, Biovica collaborates with pharmaceutical companies, oncologists, and researchers to advance cancer diagnostics and improve patient outcomes. Their DiviTum TKa method and kit are protected by US patents and have gained recognition in 49 countries. Committed to innovation and scientific excellence, Biovica continues to contribute to the field of oncology through their publications, pharma projects, and partnerships with international distributors.
Generated from the website